Last reviewed · How we verify
NCT05723328
Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma
NA trial testing Group Music Therapy Advocacy Recording Intervention (MTAR) in Mental Health Issues in 7 participants. Terminated before completion.
26 April 2023
Quick facts
| Lead sponsor | Hackensack Meridian Health |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 7 |
| Start date | 25 April 2023 |
| Primary completion | 26 April 2023 |
| Estimated completion | 26 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Group Music Therapy Advocacy Recording Intervention (MTAR)
Conditions studied
- Mental Health Issues — all drugs for Mental Health Issues →
- Bipolar Disorder — all drugs for Bipolar Disorder →
- Depressive — all drugs for Depressive →
- Schizophrenia Spectrum and Other Psychotic Disorders — all drugs for Schizophrenia Spectrum and Other Psychotic Disorders →
Sponsor
Hackensack Meridian Health — full company profile →
Who can join
Adults 18 to 65, any sex, with Mental Health Issues or Bipolar Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will use a systematic music therapy intervention on patients with mental illness trying to help them with their internalized stigma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05723328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Health Issues
Currently open trials in the same condition.
- NCT06832462 — A Prospective and Experimental Study on Efficacy of One-Day of Acceptance and Commitment Therapy on Mental Health Among · NA · active not recruiting
Other Hackensack Meridian Health trials
Trials by the same sponsor.
- NCT06785402 — Ceftriaxone for Post-Treatment Lyme Disease · Phase 1, PHASE2 · recruiting
- NCT06987708 — Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers · NA · not yet recruiting
- NCT06575894 — Implementing Mental Health Programs Across Communities in Iowa & Indiana for Transformation · NA · not yet recruiting
- NCT07442669 — Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration · NA · not yet recruiting
- NCT06991166 — OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05723328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hackensack Meridian Health
- Last refreshed: 5 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05723328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing